Ultraviolet-based biophotonic technologies for control and prevention of COVID-19, SARS and related disorders

• The COVID-19 pandemic led to a global shortage of personal protective equipment (PPE), physicians, negative pressure rooms, and hospital beds. • UV strategies have been developed to extend the lifespan of medical equipment as well as disinfect environmental surfaces. • Regulatory mechanisms to spe...

Descripción completa

Detalles Bibliográficos
Autor principal: Nogueira, Marcelo Saito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308021/
https://www.ncbi.nlm.nih.gov/pubmed/32585400
http://dx.doi.org/10.1016/j.pdpdt.2020.101890
Descripción
Sumario:• The COVID-19 pandemic led to a global shortage of personal protective equipment (PPE), physicians, negative pressure rooms, and hospital beds. • UV strategies have been developed to extend the lifespan of medical equipment as well as disinfect environmental surfaces. • Regulatory mechanisms to speed up development and approval of technologies and medicines against COVID-19 have been issued. • Opportunities to scale the production of UV devices for microbial inactivation are vast. • Development of reliable and safe technology to ensure the safety of healthcare workers and contain the virus spreading is the main priority.

Ejemplares similares